How Compensation Works in the GLP-1 Litigation

Marin & MurphySuper Lawyers® 2014–2024(888) 348-2735

Ozempic (GLP-1) Lawsuit — Free Case Review

No Settlement Exists — Here's What Does

Anyone quoting amounts is guessing. What's real is eligibility — see whether your diagnosis, testing, and dates qualify.

No Ozempic or other GLP-1 lawsuit has been settled, and no court or jury has found that these medications caused anyone's injury — the litigation is ongoing, with major expert-evidence rulings still ahead. Whether any individual has a claim depends on their own medical records and the law of their state.

Did this happen to you — or someone you love?

Start your free case reviewTell us anyway

Answered 24/7 · Free & confidential · No fee unless there is a recovery. Court costs and litigation expenses are advanced by counsel and repaid from the recovery. You are not responsible for court costs or litigation expenses if there is no recovery, unless a court directs otherwise. The attorney's fee is a percentage of the gross recovery, calculated before expenses are deducted.

(888) 348-2735

Partners

Matthew T. Marin & Stefanie A. Murphy

Super Lawyers® honorees · American Association for Justice members

Ozempic inquiries get a personal review — and an honest answer either way, free and without obligation.

No Ozempic or other GLP-1 lawsuit has been settled, and no court or jury has found that these medications caused anyone's injury — the litigation is ongoing, with major expert-evidence rulings still ahead. Whether any individual has a claim depends on their own medical records and the law of their state. Do not stop, start, or change any prescribed medication because of anything on this page. Those decisions belong with your prescriber. Attorney Advertising.

GLP-1 injury cases are handled on a contingency basis — no fee unless there is a recovery — so there is nothing to pay up front. Compensation in a mass tort is determined case by case, from an individual’s medical records, injury severity and losses, and the law of their state. Nobody can tell you what a GLP-1 claim is worth today, because none has been settled and no court or jury has decided one. Any page quoting a figure is describing a projection, not an outcome.

What “no fee unless there is a recovery” actually means

The firm’s fee is contingent on obtaining a recovery for you. If there is no recovery, there is no attorney fee. You do not pay an hourly rate or a retainer, and you are not billed for the evaluation of your claim.

The fee is an agreed percentage of any recovery, set out in a written agreement you sign before work begins. Case costs — record retrieval, filing fees, expert work — are handled under that same agreement. Read it and ask questions before signing. The review itself is free, confidential, and carries no obligation; contacting the firm does not create an attorney-client relationship.

Why nobody can quote you a number today

As of today there is no settlement in any GLP-1 personal-injury case anywhere. There is no verdict, no settlement program, no claims administrator, and no trial date in either federal proceeding.

Compensation figures in a mass tort come from verdicts establishing what juries award, or from a negotiated structure assigning values to categories of injury. Neither exists here yet. Any estimated range or per-person figure circulating for GLP-1 claims is a projection, not a description of anything paid to anyone.

How mass-tort compensation is determined

Consolidating cases into a multidistrict litigation does not merge them into one claim with one payment. An MDL is a pretrial management device: cases are gathered before one judge to resolve shared questions, and each case otherwise remains an individual lawsuit belonging to an individual person.

If a mass tort resolves, compensation is normally worked out case by case, or through a structure sorting claims by documented severity and proof. Either way the driver is what an individual claimant’s records establish. Two people who took the same medication for the same length of time can end up in very different positions because one has objective testing and documented permanent impairment and the other has symptoms never worked up. The records are the case.

What affects an individual outcome

• Which track the claim falls into — separate proceedings at different stages, with different criteria and evidence.
• Objective documentation of the diagnosis — a properly performed gastric emptying study; for obstruction, other objective testing; for NAION, an actual diagnosis.
• Severity and permanence — ER visits, hospital admissions, surgery, nutritional support, and the degree of permanent vision impairment.
• Documented economic losses — medical expenses and time out of work.
• Proof of brand-name use — pharmacy fill records showing which product was taken and when.
• Timing of the diagnosis relative to the period of use, treated differently in each track.
• The law of your state — deadlines, comparative-fault and damages rules all vary.
• How the litigation develops — rulings on expert evidence and causation will shape every claim.

What the process looks like

A review starts with a short set of questions about medications, brands, dates, diagnoses and treatment. If the facts fit the current criteria, the next step is gathering records — pharmacy fill history, the diagnosing physician’s records, hospital records — which answers most eligibility questions by replacing recollection with documents. Cases that proceed are filed and, if federal, transferred into the appropriate consolidated proceeding. Anyone offering you a completion date is guessing.

The honest picture

In August 2025 the court overseeing the stomach-injury cases ruled that a plaintiff claiming gastroparesis must show a diagnosis based on a properly performed gastric emptying study. That is a real narrowing of who can bring that claim, and many people correctly diagnosed by a physician never received that test. Expert-evidence motions there are fully briefed and being heard September 14 through 18, 2026. European regulators concluded in June 2025 that NAION is a very rare side effect of semaglutide medicines; the NAION proceeding has issued no merits rulings. Both manufacturers dispute causation.

Common questions

Common questions: can you sue?, it’s not about your doctor, still taking Ozempic?, is it too late to file?, still on a GLP-1, stopped taking it, switched drugs, and calling for a parent.